新闻
CNCE
--
0.00%
--
瑞穗维持对 Concert Pharmaceuticals 的买入,将目标价下调至 9 美元
Mizuho analyst Difei Yang maintains Concert Pharmaceuticals (NASDAQ:CNCE) with a Buy and lowers the price target from $13 to $9.
Benzinga · 10/05 11:31
我们认为 Concert Pharmaceuticals(纳斯达克股票代码:CNCE)需要谨慎推动业务增长
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Simply Wall St. · 09/22 10:53
Concert Pharmaceuticals 赞助的一项名为“评估 CTP-543 在成人斑秃患者中的安全性和有效性的欧洲扩展研究”发布到 ClinicalTrials.Gov 网站;研究尚未招聘
https://clinicaltrials.gov/ct2/show/NCT05041803
Benzinga · 09/13 13:42
Concert Pharmaceuticals 将出席即将举行的投资者会议
LEXINGTON, Mass., September 03, 2021--In September, Concert will present virtually at the HC Wainwright and Cantor healthcare conferences.
Business Wire · 09/03 11:00
为纪念斑秃宣传月,地标和桥梁将在整个 9 月点亮蓝色
LEXINGTON, Mass., August 31, 2021--Landmarks across the USA will light it up blue for alopecia areata awareness month, which is recognized annually during September.
Business Wire · 08/31 11:00
调查 Concert Pharmaceuticals 的资本使用回报率
After pulling data from Benzinga Pro it seems like during Q2, Concert Pharmaceuticals (NASDAQ:CNCE) earned $6.22 million, a 125.93% increase from the preceding quarter.
Benzinga · 08/27 21:12
The Daily Biotech Pulse:AzurRx 关注数据,Agios 的 Mitapivat 监管申请获得优先审查接受,FDA 批准葛兰素史克
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
Benzinga · 08/18 11:37
12 只医疗保健股在周二的盘后交易时段内移动
Gainers
Benzinga · 08/10 20:52
每日生物技术脉搏:默克报告了积极的 Keytruda 读数,尽管第二季度节拍,Moderna 下滑,拜耳以高达 $2B 的价格购买 Vividion,GlycoMimetics 获得新的首席执行官
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)
Benzinga · 08/05 12:04
Concert Pharmaceuticals 第二季度每股收益 0.16 美元,同比增长(0.41 美元),销售额 3202 万美元,同比增长 639 万美元
Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly earnings of $0.16 per share. This is a 139.02 percent increase over losses of $(0.41) per share from the same period last year. The company reported $32.02
Benzinga · 08/05 11:20
Concert Pharma 每股收益超过 0.58 美元,高于收入
Concert Pharma (NASDAQ:CNCE): Q2 GAAP EPS of -$0.16 beats by $0.58. Revenue of $32M (+400.0% Y/Y) beats by $31.95M. Cash, cash equivalents and investments as of June 30, 2021 totaled
Seekingalpha · 08/05 11:12
Concert Pharmaceuticals 报告 2021 年第二季度财务业绩
--Conference Call Scheduled Today at 8:30 a.m. ET
Business Wire · 08/05 11:00
-- 收益快报 (CNCE) CONCERT PHARMACEUTICALS 报告第二季度收入为 3200 万美元
MT Newswires · 08/05 07:28
生物技术的未来一周(8 月 1 日至 7 日):生物制药收益加快,伊顿公学等待 FDA 的决定,专注于待定的临床读数和 IPO
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
Benzinga · 08/01 14:13
分析师估计 Concert Pharmaceuticals (CNCE) 报告收益下降:需要注意什么
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 19:04
Concert Pharmaceuticals 将于 2021 年 8 月 5 日报告 2021 年第二季度业绩
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2021, on Thursday, August 5, 2021, before the U.S. financial markets open. The Company will host a conference call and webcast ...
Business Wire · 07/29 11:00
每日生物技术脉搏:Ardelyx 因监管挫折而下沉,AnPac 发布积极的预告,欧洲对 Myovant 点头,HCW Biologics 在华尔街首次亮相
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)
Benzinga · 07/20 12:19
周一触及 52 周低点的股票
  Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.
Benzinga · 07/19 14:04
The Daily Biotech Pulse:Moderna 加入标准普尔 500 指数,不赞成 FibroGen 的贫血药物,Corvus 搁置 COVID 研究
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)
Benzinga · 07/16 11:37
The Daily Biotech Pulse:ScPharma 的积极数据,礼来去购物,LeMaitre 预先宣布第二季度收入
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13)
Benzinga · 07/14 11:48
微牛提供丰富的实时CNCE股票新闻,让你可以通过多个平台了解CNCE股票行情最新动态,这些免费的Concert Pharma新闻可以帮助你做出明智投资。
CNCE 简况
Concert Pharmaceuticals, Inc.是一家临床阶段的生物制药公司。该公司从事小分子药物的发现与开发。该公司通过自行开发药品或与其他部门合作从事经营。该公司的处于开发阶段的临床候选药物包括AVP-786、CTP-656、CTP-730和JZP-386。该公司的氘化化学实体平台(DCE平台)帮助其识别氘化化合物,并设计、评估、开发和制造氘代化合物。该公司正在利用其DCE平台发现和开发治疗多种适应症的候选产品。该公司的候选产品CTP-656是该公司最初开发的治疗门控突变患者(包括G551D突变)的囊性纤维化的下一代增效剂。AVP-786是氘代右美沙芬类似物和低剂量奎尼丁的组合。